Acurx Pharmaceuticals, Inc. (ACXP)
Nasdaq: ACXP · CIK 0001736243 · United States
Every official Acurx Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ACXP filings
Acurx Pharmaceuticals, Inc. documents
- Acurx Pharmaceuticals, Inc. 10-K 2026ACXP 10-K 2026: annual report for fiscal 2026
- Acurx Pharmaceuticals, Inc. 10-K 2025ACXP 10-K 2025: annual report for fiscal 2025
- Acurx Pharmaceuticals, Inc. 10-K 2024ACXP 10-K 2024: annual report for fiscal 2024
- Acurx Pharmaceuticals, Inc. 10-K 2023ACXP 10-K 2023: annual report for fiscal 2023
- Acurx Pharmaceuticals, Inc. 10-K 2022ACXP 10-K 2022: annual report for fiscal 2022
- Acurx Pharmaceuticals, Inc. 10-Q 2026ACXP 10-Q 2026: quarterly report for fiscal 2026
- Acurx Pharmaceuticals, Inc. 10-Q 2025ACXP 10-Q 2025: quarterly report for fiscal 2025
- Acurx Pharmaceuticals, Inc. 10-Q 2024ACXP 10-Q 2024: quarterly report for fiscal 2024
- Acurx Pharmaceuticals, Inc. 10-Q 2023ACXP 10-Q 2023: quarterly report for fiscal 2023
- Acurx Pharmaceuticals, Inc. 10-Q 2022ACXP 10-Q 2022: quarterly report for fiscal 2022
- Acurx Pharmaceuticals, Inc. 8-K 2026ACXP 8-K 2026: current report for fiscal 2026
- Acurx Pharmaceuticals, Inc. 8-K 2025ACXP 8-K 2025: current report for fiscal 2025
- Acurx Pharmaceuticals, Inc. 8-K 2024ACXP 8-K 2024: current report for fiscal 2024
- Acurx Pharmaceuticals, Inc. 8-K 2023ACXP 8-K 2023: current report for fiscal 2023
- Acurx Pharmaceuticals, Inc. 8-K 2022ACXP 8-K 2022: current report for fiscal 2022
- Acurx Pharmaceuticals, Inc. DEF 14A 2026ACXP DEF 14A 2026: proxy statement for fiscal 2026
- Acurx Pharmaceuticals, Inc. DEF 14A 2025ACXP DEF 14A 2025: proxy statement for fiscal 2025
- Acurx Pharmaceuticals, Inc. DEF 14A 2024ACXP DEF 14A 2024: proxy statement for fiscal 2024
- Acurx Pharmaceuticals, Inc. DEF 14A 2023ACXP DEF 14A 2023: proxy statement for fiscal 2023
- Acurx Pharmaceuticals, Inc. DEF 14A 2022ACXP DEF 14A 2022: proxy statement for fiscal 2022
- Acurx Pharmaceuticals, Inc. Form 4 2026ACXP Form 4 2026: insider trading filing for fiscal 2026
- Acurx Pharmaceuticals, Inc. Form 4 2025ACXP Form 4 2025: insider trading filing for fiscal 2025
- Acurx Pharmaceuticals, Inc. Form 4 2024ACXP Form 4 2024: insider trading filing for fiscal 2024
- Acurx Pharmaceuticals, Inc. Form 4 2023ACXP Form 4 2023: insider trading filing for fiscal 2023
- Acurx Pharmaceuticals, Inc. Form 4 2022ACXP Form 4 2022: insider trading filing for fiscal 2022
- Acurx Pharmaceuticals, Inc. S-1 2026ACXP S-1 2026: registration statement for fiscal 2026
- Acurx Pharmaceuticals, Inc. S-1 2025ACXP S-1 2025: registration statement for fiscal 2025
- Acurx Pharmaceuticals, Inc. S-1 2024ACXP S-1 2024: registration statement for fiscal 2024
- Acurx Pharmaceuticals, Inc. S-1 2023ACXP S-1 2023: registration statement for fiscal 2023
- Acurx Pharmaceuticals, Inc. S-1 2022ACXP S-1 2022: registration statement for fiscal 2022
- Acurx Pharmaceuticals, Inc. 13F 2026ACXP 13F 2026: institutional holdings for fiscal 2026
- Acurx Pharmaceuticals, Inc. 13F 2025ACXP 13F 2025: institutional holdings for fiscal 2025
- Acurx Pharmaceuticals, Inc. 13F 2024ACXP 13F 2024: institutional holdings for fiscal 2024
- Acurx Pharmaceuticals, Inc. 13F 2023ACXP 13F 2023: institutional holdings for fiscal 2023
- Acurx Pharmaceuticals, Inc. 13F 2022ACXP 13F 2022: institutional holdings for fiscal 2022
More companies